| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |